B.N. Hoogeboom

Faculty of Medical Sciences

Telephone:

E-mail:

b.n.hoogeboom umcg.nl

Research Portal

Publications

Effect of repurposed metabolic drugs on human macrophage polarization and antitumoral activity

Vizcaino-Castro, A., Chen, S., Hoogeboom, B. N., Boerma, A., Daemen, T. & Oyarce, C., Mar-2025, In: Clinical Immunology. 272, 10 p., 110440.

Research output: Contribution to journal › Article › Academic › peer-review

Programming alphavirus with IFN-γ overrides the adverse effects of macrophages on oncolytic virotherapy

Horváthová, L., Hoogeboom, B. N., Janzen, T., Weissing, F., Daemen, T. & Bhatt, D., 16-Feb-2025, BioRxiv, 26 p.

Research output: Working paper › Preprint › Academic

An in vitro CD8 T-cell priming assay enables epitope selection for hepatitis C virus vaccines

Koutsoumpli, G., Stasiukonyte, N., Hoogeboom, B. N. & Daemen, T., 17-Sept-2024, In: Vaccine. 42, 22, 10 p., 126032.

Research output: Contribution to journal › Article › Academic › peer-review

Oncolytic alphavirus replicons mediated recruitment and activation of T cells

Bhatt, D. K., Meuleman, S. L., Hoogeboom, B. N. & Daemen, T., 15-Mar-2024, In: Iscience. 27, 3, 16 p., 109253.

Research output: Contribution to journal › Article › Academic › peer-review

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

Komdeur, F. L., Singh, A., van de Wall, S., Meulenberg, J. J. M., Boerma, A., Hoogeboom, B. N., Paijens, S. T., Oyarce, C., de Bruyn, M., Schuuring, E., Regts, J., Marra, R., Werner, N., Sluis, J., van der Zee, A. G. J., Wilschut, J. C., Allersma, D. P., van Zanten, C. J., Kosterink, J. G. W. & Jorritsma-Smit, A.& 3 others, Yigit, R., Nijman, H. W. & Daemen, T., 3-Feb-2021, In: Molecular Therapy. 29, 2, p. 611-625 15 p.

Research output: Contribution to journal › Article › Academic › peer-review

Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?

Koutsoumpli, G., Ip, P. P., Schepel, I., Hoogeboom, B. N., Boerma, A. & Daemen, T., 1-Jan-2019, In: Therapeutic Advances in Vaccines and Immunotherapy. 7, p. 1-13 13 p.

Research output: Contribution to journal › Article › Academic › peer-review

A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development

Draghiciu, O., Boerma, A., Hoogeboom, B. N., Nijman, H. W. & Daemen, T., 2015, In: OncoImmunology. 4, 10, 9 p., 1029699.

Research output: Contribution to journal › Article › Academic › peer-review

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

Draghiciu, O., Nijman, H. W., Hoogeboom, B. N., Meijerhof, T. & Daemen, T., Mar-2015, In: OncoImmunology. 4, 3, 11 p., 989764.

Research output: Contribution to journal › Article › Academic › peer-review

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7

van de Wall, S., Walczak, M., van Rooij, N., Hoogeboom, B.-N., Meijerhof, T., Nijman, H. W. & Daemen, T., 24-Mar-2015, In: Vaccines. 3, 2, p. 221-238 18 p.

Research output: Contribution to journal › Article › Academic › peer-review

Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination

Draghiciu, O., Walczak, M., Hoogeboom, B. N., Franken, K. L. M. C., Melief, K. J. M., Nijman, H. W. & Daemen, T., 15-Feb-2014, In: International Journal of Cancer. 134, 4, p. 859-872 14 p.

Research output: Contribution to journal › Article › Academic › peer-review

All (20) publications

View full research profile